Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleArsenic trioxide in ovarian cancer
dc.contributor.authorONG PEI SHI
dc.identifier.citationONG PEI SHI (2008-09-14). Arsenic trioxide in ovarian cancer. ScholarBank@NUS Repository.
dc.description.abstractArsenic trioxide (As2O3) has shown anti-tumour activity against a variety of solid tumours in vitro. However, the mechanisms responsible for its cytotoxicity against ovarian carcinoma remain elusive. In this thesis, the molecular determinants of its effects and factors mediating its chemoresistance in ovarian cancer cells were investigated. It was found that As2O3 treatment caused both apoptosis induction and caspase-independent cell death involving mitochondrial dysfunction. This was accompanied by endoplasmic reticulum stress induction and an increase in intracellular glutathione (GSH) level. The latter was in turn prevented by the concurrent use of GSH modulator, buthionine sulfoximine but not ascorbic acid. Gene expression analysis of arsenic-resistant OVCAR-3 (OVCAR-3/AsR) cells showed the involvement of multiple factors mediating its chemoresistance. Of particular interest, a genetic hub involving elevated interleukin 1A signalling was identified. This could consecutively modulate the expression of other genes, thus promoting and ensuing the continual growth and survival of OVCAR-3/AsR cells.
dc.subjectArsenic Trioxide; Ovarian cancer; Mitochondrial dysfunction; Caspase-independent cell death; Endoplasmic reticulum stress; glutathione
dc.contributor.supervisorHO CHI LUI, PAUL
dc.contributor.supervisorCHAN SUI YUNG
dc.description.degreeconferredDOCTOR OF PHILOSOPHY
Appears in Collections:Ph.D Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Ong PSupdated.pdf9.67 MBAdobe PDF



Page view(s)

checked on Sep 22, 2022


checked on Sep 22, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.